Evidence map›Paper›PMID 20354024›Full record

ArticleBMJ (Clinical research ed.)2010

WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study.

Behzad Nadjm, Ben Amos, George Mtove, Jan Ostermann, Semkini Chonya, Hannah Wangai, Juma Kimera, Walii Msuya, Frank Mtei, Denise Dekker and 5 more

Open access · hybridAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 8 pooled it
26.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 8 syntheses or guidelines pooled it, 172 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Compliance With Referral Advice After Treatment With Prereferral Rectal Artesunate: A Study in 3 Sub-Saharan African Countries.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Trial
  12. Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
    Trial
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Observational
  18. A Systemic Review on Fitness and Survival ofIndian journal of microbiology · 2024
    Review
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Behzad NadjmLondon School of Hygiene and Tropical Medicine, London WCIE 7HT.
Ben Amos
George Mtove
Jan Ostermann
Semkini Chonya
Hannah Wangai
Juma Kimera
Walii Msuya
Frank Mtei
Denise Dekker
Rajabu Malahiyo
Raimos Olomi
John A Crump
Christopher J M Whitty
Hugh Reyburn
Kilimanjaro Christian Medical Centre · TZRajabu St Augustine's, Hospitali Teule · TZLondon School of Hygiene & Tropical Medicine · GBDuke Medical Center · USDuke University · USNational Institute for Medical Research · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the performance of WHO's "Guidelines for care at the first-referral level in developing countries" in an area of intense malaria transmission and identify bacterial infections in children with and without malaria.

designProspective study.

settingDistrict hospital in Muheza, northeast Tanzania.

participantsChildren aged 2 months to 13 years admitted to hospital for febrile illness.

main outcome measuresSensitivity and specificity of WHO guidelines in diagnosing invasive bacterial disease; susceptibility of isolated organisms to recommended antimicrobials.

resultsOver one year, 3639 children were enrolled and 184 (5.1%) died; 2195 (60.3%) were blood slide positive for Plasmodium falciparum, 341 (9.4%) had invasive bacterial disease, and 142 (3.9%) were seropositive for HIV. The prevalence of invasive bacterial disease was lower in slide positive children (100/2195, 4.6%) than in slide negative children (241/1444, 16.7%). Non-typhi Salmonella was the most frequently isolated organism (52/100 (52%) of organisms in slide positive children and 108/241 (45%) in slide negative children). Mortality among children with invasive bacterial disease was significantly higher (58/341, 17%) than in children without invasive bacterial disease (126/3298, 3.8%) (P<0.001), and this was true regardless of the presence of P falciparum parasitaemia. The sensitivity and specificity of WHO criteria in identifying invasive bacterial disease in slide positive children were 60.0% (95% confidence interval 58.0% to 62.1%) and 53.5% (51.4% to 55.6%), compared with 70.5% (68.2% to 72.9%) and 48.1% (45.6% to 50.7%) in slide negative children. In children with WHO criteria for invasive bacterial disease, only 99/211(47%) of isolated organisms were susceptible to the first recommended antimicrobial agent.

conclusionsIn an area exposed to high transmission of malaria, current WHO guidelines failed to identify almost a third of children with invasive bacterial disease, and more than half of the organisms isolated were not susceptible to currently recommended antimicrobials. Improved diagnosis and treatment of invasive bacterial disease are needed to reduce childhood mortality.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsBacteriological TechniquesChildChild, PreschoolHIV SeropositivityHospitalizationHumansInfantMalaria, FalciparumPractice Guidelines as TopicProspective StudiesSensitivity and SpecificityTanzaniaAnti-Bacterial Agents

Identifiers

PMID20354024
PMCPMC2847687
OpenAlexW1996766178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.